Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Arsenault

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Rheumatology|October 4, 2011
An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgiaLynne Pauer, Andreas Winkelmann, Pierre Arsenault, et al.
Pain Reports|February 2, 2019
NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee painPierre Arsenault, Dan Chiche, William Brown, et al.
Current Medical Research and Opinion|March 10, 2017
Corrections to: Once-daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled studyLesley M Arnold, Pierre Arsenault, Cynthia Huffman, et al.
The Journal of Rheumatology|June 3, 2015
Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication: A Randomized, Placebo-controlled StudyLesley M Arnold, Piercarlo Sarzi-Puttini, Pierre Arsenault, et al.
Current Medical Research and Opinion|May 29, 2014
Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled studyLesley M Arnold, Pierre Arsenault, Cynthia Huffman, et al.
Canadian Family Physician Medecin De Famille Canadien|September 14, 2019
Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?Alan Kaplan, Pierre Arsenault, Brian Aw, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Rheumatology|October 4, 2011
An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgiaLynne Pauer, Andreas Winkelmann, Pierre Arsenault, et al.
Pain Reports|February 2, 2019
NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee painPierre Arsenault, Dan Chiche, William Brown, et al.
Current Medical Research and Opinion|March 10, 2017
Corrections to: Once-daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled studyLesley M Arnold, Pierre Arsenault, Cynthia Huffman, et al.
The Journal of Rheumatology|June 3, 2015
Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication: A Randomized, Placebo-controlled StudyLesley M Arnold, Piercarlo Sarzi-Puttini, Pierre Arsenault, et al.
Current Medical Research and Opinion|May 29, 2014
Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled studyLesley M Arnold, Pierre Arsenault, Cynthia Huffman, et al.
Canadian Family Physician Medecin De Famille Canadien|September 14, 2019
Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?Alan Kaplan, Pierre Arsenault, Brian Aw, et al.
Pageof 2